...
首页> 外文期刊>Indian journal of dermatology >CD3+, CD56+, CD4?, CD8?, CD20?, CD30? Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
【24h】

CD3+, CD56+, CD4?, CD8?, CD20?, CD30? Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report

机译:CD3 +,CD56 +,CD4?,CD8?,CD20?,CD30?外周T细胞非霍奇金淋巴瘤:罕见病例报告

获取原文
           

摘要

Cutaneous T-cell lymphoma (CTCL) commonly presents as mycosis fungoides or Sezary syndrome, both having CD4 positivity. A subset of CTCL which lacks CD4 surface marker is classified as cutaneous g and d –T-cell lymphoma (CGD-TCL). Because of its rarity and inability to study large number of patients, the impact of immunophenotype on the clinical outcome of primary CTCL in patients is limited. We report a case of primary CGD-TCL in a 71-year-old male because of this rarity and to emphasize its aggressive nature.
机译:皮肤T细胞淋巴瘤(CTCL)通常表现为真菌病或Sezary综合征,两者均具有CD4阳性。缺少CD4表面标记的CTCL子集被分类为皮肤性g和d-T细胞淋巴瘤(CGD-TCL)。由于其稀有性且无法研究大量患者,因此免疫表型对患者原发性CTCL临床结果的影响是有限的。由于这种稀有性,我们报道一例71岁男性的原发性CGD-TCL,并强调其侵略性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号